Stock Events

Stock Events

Franklin Genomic Advancements

$34.7

0

+$0+0% Monday 02:25

Statistics

Day High

34.7

Day Low

34.7

52W High

-

52W Low

-

Volume

3

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

0.41%

Dividend

0.14

Upcoming

Dividend Payment

Dividend Payment

Dividends

0.41%Dividend Yield

Jan 26

$0.14

Jan 22

$0

Dec 21

$0.11

Dec 20

$0.05

10Y Growth

N/A

5Y Growth

3.95%

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HELX.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with HELX's investment focus.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF invests in companies involved in genomics and biotechnology, offering direct competition to HELX by targeting similar advancements and technologies in the genomic space.

iShares Genomics Immunology and Healthcare

iShares Genomics Immunology and Healthcare ETF targets companies in the genomics, immunology, and bioengineering sectors, competing with HELX by investing in the rapidly evolving genomics industry.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF focuses on companies that are leading the charge in healthcare innovation, including genomics and biotechnology, positioning it as a competitor to HELX.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF invests in companies that are principally engaged in the research, development, manufacture, and distribution of various biotechnological products, therapies, and services, including genomic research, competing directly with HELX's focus.

VanEck Vectors Biotech ETF includes holdings in biotechnology companies involved in the use of biological and genetic knowledge to develop new therapies and products, competing with HELX in the genomic advancements space.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund is composed of firms in the biotechnology sector, which includes genomic research and development, making it a competitor to HELX.

iShares Biotechnology

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, which includes companies involved in genomic and genetic research, competing with HELX's investment strategy.

State Street SPDR S&P Biotech

SPDR S&P Biotech ETF provides exposure to the biotech sector, including genomic research and development companies, making it a competitor to HELX.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF invests in companies with one or more drugs in Phase II or Phase III FDA clinical trials, which often include genomic and genetic research companies, positioning it as a competitor to HELX.

Holdings

Regions

Sectors

About

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Show more...

CEO

ISIN

US35473P5200

Listings

0 Comments

Share your thoughts

FAQ

What is Franklin Genomic Advancements stock price today?▼

The current price of HELX.BOATS is $34.7 USD — it has increased by +0% in the past 24 hours. Watch Franklin Genomic Advancements stock price performance more closely on the chart.

What is Franklin Genomic Advancements stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Franklin Genomic Advancements stocks are traded under the ticker HELX.BOATS.

Does Franklin Genomic Advancements pay dividends?▼

Yes, HELX.BOATS dividends are paid annual. The last dividend per share was 0.14 USD. As of today, Dividend Yield (FWD)% is 0.41%.

When did Franklin Genomic Advancements complete a stock split?▼

Franklin Genomic Advancements has not had any recent stock splits.